Zila buys rights to light technology
This article was originally published in Clinica
Executive Summary
Oral soft tissue management company Zila has bought the worldwide marketing rights to the FDA-cleared ViziLite chemiluminescent light technology from Trylon, which gets up to 2 million Zila shares. Trylon will also get royalties on sales - 10% for the first five years and 5% for the following five years.